Rhythm Phar­ma­ceu­ti­cals is look­ing to ex­pand the po­ten­tial mar­ket for its rare obe­si­ty treat­ment Im­civree be­yond ge­net­ic dis­or­ders.

Phase Two consists of the next three weeks of the program. On-field workouts may include individual or group instruction and drills, as well as "perfect play drills," and drills and plays with ...

Check out the schedule for Kansas City down below: Phase Two consists of the next three weeks of the program. On-field workouts may include individual or group instruction and drills, as well as ...

US President Donald Trump’s State Department was supposed to keep sensitive information about foreign grants private. It all leaked, sources told the Rolling Stone on Saturday. According to the ...

With phase three of TDOT’s I-65 widening project kicking off Friday night, leaders say it will help address congestion, improve safety and meet traffic demands by expanding the interstate form ...

Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa, which failed to show significant overall survival benefits in PROC. The trial's failure delays ...

The Union Bank Local Bank Officer Interview Call Letter 2025 is now available on the official website. Candidates can download it by entering their Registration Number and Password or Date of Birth.

Shortly after paying $800 million to take full control of BNT327, the biotech began a phase 3 trial to test the bispecific in combination with chemo in patients with previously untreated extensive ...

The statistically significant responder analysis results for Mytesi ® (crofelemer) in the OnTarget study’s prespecified subgroup of patients with breast cancer were the subject of a December 2024 ...

A pen­ny stock biotech re­port­ed that its acute graft-ver­sus-host dis­ease drug failed a late-stage tri­al, but it still plans to seek ac­cel­er­at­ed ap­proval.

XYNGARI™ is the first once-weekly topical product candidate to demonstrate clinical benefit in a Phase 3 clinical trial for moderate-to-severe acne- - Over 30 million acne patients seek ...

A phase 2 trial will evaluate leronlimab’s safety and efficacy ... their viral load must be below 50 copies/ml and the patient must be on stable ART for at least 3 months. Patients are required to ...